Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$8.82 - $11.12 $43,218 - $54,487
4,900 Added 34.75%
19,000 $211,000
Q4 2023

Oct 21, 2024

SELL
$6.48 - $11.61 $777 - $1,393
-120 Reduced 0.84%
14,100 $158,000
Q4 2023

Feb 07, 2024

BUY
$6.48 - $11.61 $91,368 - $163,701
14,100 New
14,100 $158,000
Q1 2023

Oct 21, 2024

BUY
$7.38 - $10.35 $104,943 - $147,177
14,220 New
14,220 $118,000
Q1 2023

May 03, 2023

SELL
$7.38 - $10.35 $49,969 - $70,079
-6,771 Reduced 32.26%
14,220 $118,000
Q4 2022

Feb 13, 2023

BUY
$7.63 - $10.22 $160,161 - $214,528
20,991 New
20,991 $201,000

Others Institutions Holding FENC

About FENNEC PHARMACEUTICALS INC.


  • Ticker FENC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,067,300
  • Market Cap $170M
  • Description
  • Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec...
More about FENC
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.